Status:
COMPLETED
THRIVE in Pediatric Laryngeal Microsurgery
Lead Sponsor:
Seoul National University Hospital
Conditions:
Laryngoscopy
Eligibility:
All Genders
Up to 6 years
Brief Summary
Transnasal High-flow rapid-insufflation ventilatory exchange (THRIVE) has been shown to benefit oxygenation, ventilation and upper airway patency in a range of clinical scenarios, however its use in s...
Eligibility Criteria
Inclusion
- pediatric patients undergoing laryngeal microsurgery with spontaneous ventilation
Exclusion
- Severe gastrointestinal reflux disease Neuromuscular disease Central hypoventilation
Key Trial Info
Start Date :
August 7 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 3 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03241979
Start Date
August 7 2017
End Date
June 3 2019
Last Update
April 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SNUH
Seoul, Jongro Gu, South Korea, 15710